| Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the … M Hoenigl, J Salmanton-García, TJ Walsh, M Nucci, CF Neoh, JD Jenks, ... The Lancet Infectious Diseases 21 (8), e246-e257, 2021 | 330 | 2021 |
| COVID-19 Infection in Adult Patients with Hematological Malignancies: A European Hematology Association Survey (EPICOVIDEHA) L Pagano, J Salmanton-García, F Marchesi J. Hematol. Oncol 14 (1), 2021 | 309 | 2021 |
| COVID-19–associated pulmonary aspergillosis, March–August 2020 J Salmanton-García, R Sprute, J Stemler, M Bartoletti, D Dupont, ... Emerging infectious diseases 27 (4), 1077, 2021 | 250* | 2021 |
| Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of … J Prattes, J Wauters, DR Giacobbe, J Salmanton-García, J Maertens, ... Clinical Microbiology and Infection 28 (4), 580-587, 2022 | 200 | 2022 |
| Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM SCA Chen, J Perfect, AL Colombo, OA Cornely, AH Groll, D Seidel, ... The Lancet Infectious Diseases 21 (12), e375-e386, 2021 | 152 | 2021 |
| Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope (R)(vol 45, pg 1, 2019) D Seidel, A Meissner, M Lackner, E Piepenbrock, J Salmanton-Garcia, ... CRITICAL REVIEWS IN MICROBIOLOGY 45 (2), 238-238, 2019 | 133* | 2019 |
| Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 M Tenbusch, S Schumacher, E Vogel, A Priller, J Held, P Steininger, ... The Lancet Infectious Diseases 21 (9), 1212-1213, 2021 | 130 | 2021 |
| Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect S Schumacher, J Salmanton-García, OA Cornely, SC Mellinghoff Infection 49, 387-399, 2021 | 100 | 2021 |
| COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA L Pagano, J Salmanton-García, F Marchesi, A López-García, S Lamure, ... Blood, The Journal of the American Society of Hematology 139 (10), 1588-1592, 2022 | 91 | 2022 |
| Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM CC Chang, TS Harrison, TA Bicanic, M Chayakulkeeree, TC Sorrell, ... The Lancet Infectious Diseases 24 (8), e495-e512, 2024 | 84 | 2024 |
| Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey L Pagano, J Salmanton-García, F Marchesi, O Blennow, ... Blood, The Journal of the American Society of Hematology 140 (26), 2773-2787, 2022 | 79 | 2022 |
| Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study M Hoenigl, J Salmanton-García, M Egger, JP Gangneux, T Bicanic, ... The Lancet Infectious Diseases 23 (6), 751-761, 2023 | 75 | 2023 |
| Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: an EPICOVIDEHA survey report O Blennow, J Salmanton‐García, P Nowak, F Itri, J Van Doesum, ... American journal of hematology 97 (8), E312-E317, 2022 | 67 | 2022 |
| The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey J Salmanton-García, M Hoenigl, JP Gangneux, E Segal, ... The Lancet Microbe 4 (1), e47-e56, 2023 | 59 | 2023 |
| COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP A Busca, J Salmanton-García, P Corradini, F Marchesi, A Cabirta, ... Blood advances 6 (7), 2427-2433, 2022 | 55 | 2022 |
| The current state of laboratory mycology in Asia/Pacific: a survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal … J Salmanton-García, WY Au, M Hoenigl, LYA Chai, H Badali, A Basher, ... International journal of antimicrobial agents 61 (3), 106718, 2023 | 53 | 2023 |
| Mucormycosis in the Middle East and North Africa: Analysis of the FungiScope® registry and cases from the literature J Stemler, K Hamed, J Salmanton‐García, A Rezaei‐Matehkolaei, ... Mycoses 63 (10), 1060-1068, 2020 | 52 | 2020 |
| European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: results from the ECMM Candida III study MC Arendrup, S Arikan-Akdagli, KM Jørgensen, A Barac, J Steinmann, ... Journal of Infection 87 (5), 428-437, 2023 | 48 | 2023 |
| Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry J Prattes, J Wauters, DR Giacobbe, K Lagrou, M Hoenigl Intensive care medicine 47 (10), 1158-1160, 2021 | 48 | 2021 |
| COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges J Prattes, P Koehler, M Hoenigl Intensive care medicine 47 (11), 1339-1340, 2021 | 39 | 2021 |
Oliver CornelyUniversity of Cologneایمیل تأیید شده در uk-koeln.de
